Home
NVNO
NVNO News

Latest enVVeno Medical Corporation (NVNO) News on December 26, 2024

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe

ACCESSWIRE

10 days ago

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website

ACCESSWIRE

a month ago

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

ACCESSWIRE

a month ago

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval

ACCESSWIRE

a month ago

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year

ACCESSWIRE

2 months ago

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year

enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)

ACCESSWIRE

2 months ago

enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)

enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering

ACCESSWIRE

3 months ago

enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering

enVVeno Medical Corporation Announces Proposed Public Offering

ACCESSWIRE

3 months ago

enVVeno Medical Corporation Announces Proposed Public Offering

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing

ACCESSWIRE

4 months ago

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing

enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)

ACCESSWIRE

4 months ago

enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)

Here's Why We're Not Too Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation

Simply Wall St.

5 months ago

Here's Why We're Not Too Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation

enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update

ACCESSWIRE

5 months ago

enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series

ACCESSWIRE

6 months ago

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series

Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting

ACCESSWIRE

6 months ago

Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting

New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024

ACCESSWIRE

6 months ago

New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024

enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update

ACCESSWIRE

8 months ago

enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update

Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium

ACCESSWIRE

8 months ago

Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024

ACCESSWIRE

8 months ago

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024

enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer

ACCESSWIRE

9 months ago

enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity

ACCESSWIRE

9 months ago

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting

ACCESSWIRE

10 months ago

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth

Simply Wall St.

10 months ago

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth

enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

ACCESSWIRE

10 months ago

enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024

ACCESSWIRE

10 months ago

Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024

Brady Corporation (BRC) Hit a 52 Week High, Can the Run Continue?

Zacks

a year ago

Brady Corporation (BRC) Hit a 52 Week High, Can the Run Continue?

Academic Report by Pixie Dust Technologies, Inc. Showcases Applicability of Gamma Wave Sound

PR Newswire

a year ago

Academic Report by Pixie Dust Technologies, Inc. Showcases Applicability of Gamma Wave Sound

Lakeland Industries Declares Cash Dividend for First Quarter 2025

ACCESSWIRE

a year ago

Lakeland Industries Declares Cash Dividend for First Quarter 2025

With 40% ownership, Pixie Dust Technologies, Inc. (NASDAQ:PXDT) insiders have a lot riding on the company's future

Simply Wall St.

a year ago

With 40% ownership, Pixie Dust Technologies, Inc. (NASDAQ:PXDT) insiders have a lot riding on the company's future

Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?

Zacks

a year ago

Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?

Associated Press Finance

a year ago

CB Financial Services: Q4 Earnings Snapshot

Business Wire

a year ago

CB Financial Services, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Declares Quarterly Cash Dividend

Investing in Provident Financial Holdings (NASDAQ:PROV) five years ago would have delivered you a 1.9% gain

Simply Wall St.

a year ago

Investing in Provident Financial Holdings (NASDAQ:PROV) five years ago would have delivered you a 1.9% gain

Invesco Closed-End Funds Declare Dividends

PR Newswire

a year ago

Invesco Closed-End Funds Declare Dividends

GuruFocus.com

a year ago

Provident Financial Holdings Inc Reports Mixed Fiscal Q2 Results Amid Economic Uncertainty

Provident Financial (PROV) Surpasses Q2 Earnings Estimates

Zacks

a year ago

Provident Financial (PROV) Surpasses Q2 Earnings Estimates

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Simply Wall St.

a year ago

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Chemung Financial (CHMG) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

a year ago

Chemung Financial (CHMG) Reports Q4 Earnings: What Key Metrics Have to Say

Iteris Sets Fiscal Third Quarter 2024 Conference Call for Thursday, February 8, 2024 at 4:30 p.m. ET

Business Wire

a year ago

Iteris Sets Fiscal Third Quarter 2024 Conference Call for Thursday, February 8, 2024 at 4:30 p.m. ET

Insiders own 28% of Annovis Bio, Inc. (NYSE:ANVS) shares but individual investors control 57% of the company

Simply Wall St.

a year ago

Insiders own 28% of Annovis Bio, Inc. (NYSE:ANVS) shares but individual investors control 57% of the company

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

Simply Wall St.

a year ago

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

GlobeNewswire

a year ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

American Resources' (AREC) Arm Executes MOU With Duesenfeld

Zacks

a year ago

American Resources' (AREC) Arm Executes MOU With Duesenfeld

Jisoo Is New Face of Alo Yoga; Pucci Debuts Yoga Collection

WWD

a year ago

Jisoo Is New Face of Alo Yoga; Pucci Debuts Yoga Collection

Footwear News

a year ago

Allbirds Names New Chief Marketing Officer and Chief Design Officer Amid Ongoing Transformation Plan

Allbirds Announces Executive Leadership Appointments

GlobeNewswire

a year ago

Allbirds Announces Executive Leadership Appointments

TRX Gold Reports First Quarter 2024 Results

GlobeNewswire

a year ago

TRX Gold Reports First Quarter 2024 Results

Canoo's Warning-Sign Move That Might Lead to a Big Payday for Investors

Motley Fool

a year ago

Canoo's Warning-Sign Move That Might Lead to a Big Payday for Investors

7 F-Rated Semiconductor Stocks to Sell in January

InvestorPlace

a year ago

7 F-Rated Semiconductor Stocks to Sell in January

Pixie Dust Technologies, Inc. Introduces Additional Pricing Option for Proprietary Speaker kikippa

PR Newswire

a year ago

Pixie Dust Technologies, Inc. Introduces Additional Pricing Option for Proprietary Speaker kikippa

Fortune Rise Acquisition Corporation Names Director Ryan Spick as Principal Executive Officer and Chief Financial Officer

ACCESSWIRE

a year ago

Fortune Rise Acquisition Corporation Names Director Ryan Spick as Principal Executive Officer and Chief Financial Officer

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

GlobeNewswire

a year ago

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

enVVeno Medical Corporation's (NASDAQ:NVNO) Path To Profitability

Simply Wall St.

a year ago

enVVeno Medical Corporation's (NASDAQ:NVNO) Path To Profitability

CB Financial Services' (NASDAQ:CBFV) investors will be pleased with their favorable 39% return over the last three years

Simply Wall St.

a year ago

CB Financial Services' (NASDAQ:CBFV) investors will be pleased with their favorable 39% return over the last three years

ACCESSWIRE

a year ago

Monterey Capital Acquisition Corporation Announces Filing of Registration Statement on Form S-4 in Connection with Its Proposed Business Combination with ConnectM

Despite Fast-paced Momentum, TransAct Technologies Incorporated (TACT) Is Still a Bargain Stock

Zacks

a year ago

Despite Fast-paced Momentum, TransAct Technologies Incorporated (TACT) Is Still a Bargain Stock

Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years

Insider Monkey

a year ago

Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years

Clough Global Equity Fund Section 19(a) Notice

ACCESSWIRE

a year ago

Clough Global Equity Fund Section 19(a) Notice

Foghorn Therapeutics Inc. (FHTX) Upgraded to Buy: Here's Why

Zacks

a year ago

Foghorn Therapeutics Inc. (FHTX) Upgraded to Buy: Here's Why

These Stocks under $10 Are Poised To Explode

Insider Monkey

a year ago

These Stocks under $10 Are Poised To Explode

Arrowmark Financial Corp. Announces Q3 2023 Results and Releases Month End Estimated Net Asset Value as of November 2023

GlobeNewswire

a year ago

Arrowmark Financial Corp. Announces Q3 2023 Results and Releases Month End Estimated Net Asset Value as of November 2023

Zacks Small Cap Research

a year ago

XFOR: Update on Phase 2 CN Trial at ASH 2023

enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

ACCESSWIRE

a year ago

enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

Aeva to Showcase World’s First Automotive-Grade FMCW 4D LiDAR for Advanced Driver Assist and Autonomy in Production Vehicles at CES 2024

Business Wire

a year ago

Aeva to Showcase World’s First Automotive-Grade FMCW 4D LiDAR for Advanced Driver Assist and Autonomy in Production Vehicles at CES 2024

Annovis Bio to Participate in the 139th Yale CEO Summit

GlobeNewswire

a year ago

Annovis Bio to Participate in the 139th Yale CEO Summit

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

GlobeNewswire

a year ago

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

U.S. Century Bank Names William Turner New Executive Vice President and Chief Credit Officer

GlobeNewswire

a year ago

U.S. Century Bank Names William Turner New Executive Vice President and Chief Credit Officer

Satellogic Receives NOAA License to Expand U.S. Government Business

Business Wire

a year ago

Satellogic Receives NOAA License to Expand U.S. Government Business

Innovative Solutions and Support's (NASDAQ:ISSC) investors will be pleased with their solid 298% return over the last five years

Simply Wall St.

a year ago

Innovative Solutions and Support's (NASDAQ:ISSC) investors will be pleased with their solid 298% return over the last five years

enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium

ACCESSWIRE

a year ago

enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium

It's Probably Less Likely That SelectQuote, Inc.'s (NYSE:SLQT) CEO Will See A Huge Pay Rise This Year

Simply Wall St.

a year ago

It's Probably Less Likely That SelectQuote, Inc.'s (NYSE:SLQT) CEO Will See A Huge Pay Rise This Year

Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023

GlobeNewswire

a year ago

Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023

Alpha Tau to Participate in November Investor Conferences

GlobeNewswire

a year ago

Alpha Tau to Participate in November Investor Conferences

Share on Social Networks: